GLPwatch

Molecular Connectomics Reveals a Glucagon-Like Peptide 1 Sensitive Neural Circuit for Satiety.

bioRxiv · 2024

Last updated 2026-05-28

In mice, the weight-loss drug liraglutide may reduce hunger by activating specific brain cells called Trh+ neurons, which then suppress other neurons (AgRP) linked to appetite. These Trh+ neurons respond to liraglutide and, when activated, lower food intake and body weight. Blocking these Trh+ neurons led to overeating, weight gain, and weakened liraglutide’s effects on weight.

AI summary of the abstract below.

JournalbioRxiv, 2024
Citations7
Relative citation ratio1.20
NIH percentile57
Molecules
Conditions studied Obesity

Abstract

Liraglutide and other agonists of the glucagon-like peptide 1 receptor (GLP-1RAs) are effective weight loss drugs, but how they suppress appetite remains unclear. One potential mechanism is by activating neurons which inhibit hunger-promoting Agouti-related peptide (AgRP) neurons of the arcuate hypothalamus (Arc). To identify these afferents, we developed a method combining rabies-based connectomics with single-nuclei transcriptomics. Applying this method to AgRP neurons predicted at least 21 afferent subtypes in the mouse mediobasal and paraventricular hypothalamus. Among these are Trh+ Arc neurons, inhibitory neurons which express the Glp1r gene and are activated by the GLP-1RA liraglutide. Activating Trh+ Arc neurons inhibits AgRP neurons and feeding in an AgRP neuron-dependent manner. Silencing Trh+ Arc neurons causes over-eating and weight gain and attenuates liraglutide's effect on body weight. Our results demonstrate a widely applicable method for molecular connectomics, comprehensively identify local inputs to AgRP neurons, and reveal a circuit through which GLP-1RAs suppress appetite.

Verbatim abstract via PubMed 37961449 ↗